Urinary cytology in cases of bladder cancer: A critical evaluation;Urinzytologie beim harnblasenkarzinom: Kritische wertung

Urologe - Ausgabe A

Volumn 42, Issue 7, 2003, Pages 908-911

  Rathert, P ^a,b  

^a Klin fur Urologie/Kinderurologie   (Germany)

^b Klin fur Urologie/Kinderurologie   (Germany)

Author keywords

Bladder cancer; Bladder tumor markers; Urinary cytology; Urothelial cancer diagnosis

Indexed keywords

FIBRIN; MATRIX PROTEIN; MONOCLONAL ANTIBODY; TUMOR MARKER;

BLADDER CANCER; CANCER CYTODIAGNOSIS; CANCER GRADING; CARCINOMA IN SITU; CELL NUCLEUS MATRIX; CYSTOSCOPY; FLUORESCENCE MICROSCOPY; HUMAN; MEDICAL LITERATURE; PROTEIN DEGRADATION; REVIEW; SERODIAGNOSIS; TRANSITIONAL CELL CARCINOMA; URETHRA; URINALYSIS; URINARY TRACT; URINE CYTOLOGY;

CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS; URINE;

EID: 0043160408     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-003-0311-x     Document Type: Review

References (27)

1. Ali-El-Dein B, El-Tabey N, Abdel-Latif M, Abdel-Rahim M, El-Bahnasawy MS (2002) Late Uroileal cancer after incorporation of ileum into the urinary tract. J Urol 167: 84-88
2. Althausen AF, Prout GRJ, Dal JJ (1976) Noninvasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 116: 575-580
3. Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM (1999) The accuracy of urinary cytology in daily practice. Cancer 87: 118-128
4. Boman H, Hedelin H, Holmang S (2002) Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence. J Urol 167: 80-83
5. Brandt H, Rathert P (1997) Diagnostik der malignen Tumore der Harnblase. Onkologe 3: 236-242
6. Brown FM (2000) Urine cytology. Is it still the gold standard for screening? Urol Clin North Am 27: 25-37
7. Ellwein L, Farrow G (1988) Urinary cytology screening: the decision facing the asymptomatic patient. Med Decis Making 8: 100-119
8. Epstein JI, Amin MB, Reuter VR, Mostofi FK, Bladder consensus conference committee (1998) The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothellial (Transitional Cell) Neoplasms of the Urinary Bladder. Am J Surg Pathol 22: 1435-1448
9. Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR (2001) Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association best practice policy, Part I: Definition, detection, prevalence, and etiology. Part II: Patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 57: 599-610
10. Kausch J, Böhle A (2001) Bladder cancer. II. Molecular aspects and diagnosis. Eur Urol 39: 498-506
11. Konety BR, Getzenberg RH (2001) Urine based markers of urological malignancy. J Urol 165: 600-611
12. Lambl WD (1856) Über Harnblasenkrebs: Ein Beitrag zur mikroskopischen Diagnostik am Krankenbette. Prager Viertelj Schrift Prakt Heilk 49: 1-32
13. Lokeshwar VB, Soloway MS (2001) Current bladder tumor tests: does their projected utility fulfill clinical necessitiy? J Urol 165: 1067-1077
14. Murphy WM, Rivera-Ramirez J, Medina CA, Wright NJ, Wajsman Z (1997) The bladder tumor antigen (BTA) Test compared to voided urine cytology in the detection of bladder neoplasms. J Urol 158: 2102-2106
15. Dr.med.N.N. (1997) "Der Kranke ist Nebensache". Der Spiegel, Heft 26: 66-71
16. Oosterlinck W (2001) The management of superficial bladder cancer. BJU International 87: 135-140
17. Papanicolaou GN, Marshall VF (1945) Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 101: 519-520
18. Rathert P, Roth S (1995) Urinzytologie. Praxis und Atlas, 3. Aufl. Springer, Berlin Heidelberg New York Tokio (ISBN: 3-540-59248-2)
19. Retz M, Lehmann J, Wullich B, Stöckle M (2001) Nachsorge des Harnblasenkarzinoms. Urologe A 40: 480-484
20. Rübben H, Otto T (2000) Molekularbiologische Diagnostik des Harnblasenkarzinom. Urologe A 39: 178-181
21. Saad A, Hanbury DC, Mc Nicholas TA, Boustead G-B, Woodman AC (2001) The early detection and diagnosis of bladder cancer: A critical review of the options. Eur Urol 39: 619-633
22. Schmitz-Dräger BJ, Goebell PJ, Ebert T, Fradet Y (2000) p53 Immunochemistry as a prognostic marker in bladder cancer. Eur Urol 38: 691-700
23. Schwalb DM, Herr HW, Fair WR (1993) The management of clinically unconfirmed positive urinary cytology. J Urol 150: 1751-1756
24. Soloway MS, Murphy WM, Johnson DE, Farrow GM, Paulson DF, Garnick MB (1990) Initial evaluation and response criteria for patients with superficial bladder cander. Br J Urol 66: 380-385
25. Wawroschek F, Rathert P (1995) Urinzytologie. Urologe A 34: 69-75
26. Wawroschek F, Stockhausen D, Rathert P (1996) Standardurinzytologie vs. Teststreifendiagnostik: Eine vergleichende prospektive Untersuchung zur Sensitivität und Spezifität in der Detektion urothelialer Karzinome. Urologe B 36: 283-286
27. Wiener HG (2001) Cytomorphology in urinary cancer care. Past Presence Future, CIP-Gegevens Koninkliyke Bibliothek, den Haag, p 48 (ISBN 90-9014853-1)